Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study - Concepedia

Concepedia

Publication | Open Access

Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study

DOI Full Paper Access

12

Citations

21

References

2021

Year

J. Connor Wells, Shaan Dudani, Chun Loo Gan, Igor Stukalin, Arun Azad, Elizabeth Liow, Frede Donskov, Takeshi Yuasa, Sumanta K. Pal, Guillermo de Velasco,

Clinical Genitourinary Cancer

Abstract

Despite availability of effective 1L therapies in recent years, 2L sunitinib continues to have clinical activity after failure of 1L IO. Further studies on optimal treatment sequencing after 1L IO progression are needed.

References

	Year	Citations

Page 1